References
- https://optn.transplant.hrsa.gov/learn/about-transplantation/history/
- Anwar ASMT, Lee JM. Medical Management of Brain-Dead Organ Donors. Acute Crit Care. 2019;34(1):14-29. doi:10.4266/ acc.2019.00430
- Nair-Collins M, Northrup J, Olcese J. Hypothalamic-Pituitary Function in Brain Death: A Review. J Intens Care Med. 2014. 31. 10.1177/0885066614527410
- Chamorro-Jambrina C, Muñoz-Ramírez MR, Martínez-Melgar JL, Pérez-Cornejo MS. Organ donor management: Eight common recommendations and actions that deserve reflection. Med Intensiva. 2017;41(9):559-568. doi:10.1016/j. medin.2017.01.012
- Hahnenkamp K, Böhler K, Wolters H, et al., Organ-Protective Intensive Care in Organ Donors. Dtsch Arztebl Int. 2016;113(3334):552-558. doi:10.3238/arztebl.2016.0552
- Shemie SD, Dhanani S, The Physiology of Brain Death and Organ Donor Management. Ped Crit Care Med. 2014 Jan 28:497–518. doi: 10.1007/978-1-4471-6362-6_38.
- Kuecuek O, Mantouvalou L, Klemz R, et al. Significant reduction of proinflammatory cytokines by treatment of the human brain dead donor. Transplantation. 2004; 78(2):197.
- Mi Z, Novitzky D, Collins J, et al. The optimal hormonal replacement modality selection for multiple organ procurement from brain-dead organ donors. Clin Epidemiol. 2015;7:17-27.
- Lindner G, Funk GC. Hypernatremia in critically ill patients. J Crit Care. 2013;28(2):216.e11-216.e2.16E20. doi:10.1016/j. jcrc.2012.05.001.
- Opdam HI, Hormonal Therapy in Organ Donors. Crit Care Clin. 2019;35(2):389-405. doi:10.1016/j.ccc.2018.11.013.
- Bajwa SJ, Haldar R, Brain death in ICU patients: Clinical significance of endocrine changes. Indian J Endocrinol Metab. 2014;18(2):229-231. doi:10.4103/2230-8210.129118
- Buchanan IA, Mehta VA, Thyroid hormone resuscitation after brain death in potential organ donors: A primer for neurocritical care providers and narrative review of the literature. Clin Neurol Neurosurg. 2018;165:96-102. doi:10.1016/j.clineuro.2018.01.004.
- Akbaş T, İbrahim EŞ, Ayhan Ö. Alterations in thyroid hormones in brain-dead patients are related to non-thyroidal illness syndrome. Endokrynologia Polska. 2018;69(5). DOI: 10.5603/EP.a2018.0056.
- Kotsch K, Ulrich F, Reutzel-Selke A, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial [published correction appears in Ann Surg. 2011 Aug;254(2):391]. Ann Surg. 2008;248(6):1042-1050. doi:10.1097/SLA.0b013e31819 0e70c.
- Meyfroidt G, Gunst J, Martin-Loeches I, et al. Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality. Intensive Care Med. 2019;45(3):343-353. doi:10.1007/s00134-019-05551-y.
- Anwar A.S.M.T., Lee J.M., Medical Management of Brain-Dead Organ Donors. Acute Crit Care. 2019;34(1):14-29. doi:10.4266/acc.2019.00430.